Get started
Ocugen, Inc.Ocugen, Inc.Ocugen, Inc.

Ocugen, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

OCGN trade ideas

OCGN Very short term I just wanted to do a quick analysis on OCGN again on a very short-term scale. The RSI is too high for my liking to enter. I think it will possibly go down a bit until it reached the resistance at around 10.5 before moving up again. A golden cross is really visible at 1-hour chart, the MACD is showing a bullish crossover and the volume is extremely high (for better or worse). I try to keep this as simple as possible as I, myself, am pretty new to market trading. If there is anything you'd like to criticize or if you just want me to simplify something, just comment. This is not financial advice! Do your own DD!
NASDAQ:OCGNLong
by Slothie
$OCGN IF CLOSED ABOVE 13.6 THE TARGET IS 27All indicators and candles are bullish except that giant doji red candle (23/4) at 13.6 if closed above it then it will form an interesting bullish pattern targeting double of 13.6 which near by 27 . Resistances as showing at 15.8 - 18.8 then 22-24-27. earning on coming days so could dump too . Now its at 12.67 - if falls down below 10 again will looks soo bearish and will cancel bullish ideas. check my previous idea for $OCGN when it was 0.8.. :)
NASDAQ:OCGNLong
by WinnerTrader99
2
OCGN will continue flyingThis is my second shot on OCGN and still a similar analysis. NASDAQ:OCGN is still a relatively small market cap that can grow very quickly. Covaxin, their covid vaccine candidate is still waiting for FDA approval. Occugen is partenering with an indian company -Bharat Biotech and have a deal with them to market Covaxin in the U.S. The vaccine is already commercialized in a couple of countries, eg. India, Mexico, the Phillippines.. OCGN will be in charge of commercializing the vaccine in the US if it's approved. The vaccine phase 3 tests showed very good results, it achieved an overall efficacy of 78% and a 100% efficacy against severe covid19. With the J&J vaccine being put on hold, Covaxin has a key role to play. Any rumours or confirmed news about the FDA approval, will send the stock above 30$.
NASDAQ:OCGNLong
by fbits10
7
Will it be different this time?The price action in the impulse 3 is slightly different than in impulse 1 and 2, also look at the RSI - Action under 1 and 2 is started to slope almost immediately , but under 3 is sideways . Will it be different this time? I do not know,I still think that probability of the price retest of value low zone is high (as it happened before in 2019-refer to the chart below) but next few days will show, at this moment I can not tell how the price action will play out.
NASDAQ:OCGN
by RotanimreT
4
$OCGN PT 180-200 and higherOcugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
NASDAQ:OCGNLong
by UnknownUnicorn19246015
7